Moderna, Merck develop mRNA vaccine against skin cancer
Moderna's stock soared Tuesday after the COVID-19 vaccine manufacturer's thorough advancement in improving a preventive shot for a dangerous form of skin cancer.
The company also said potential melanoma vaccine it is testing with…